Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (33)
- Import and export (31)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Search
1279 result(s) found, displaying 1226 to 1250
-
Market actionsBleph-10 (sulfacetamide sodium 10%) 15 mL eye drops
-
Market actions
-
Market actionsMYCOSPOR Bifonazole cream, CANESTEN Bifonazole Once Daily Anti-Fungal Body Cream
-
-
Market actionsBenadryl for the Family Dry Cough and Nasal Congestion Liquid
-
Safety alertsWe are advising that products containing Greater Celandine (Chelidonium majus) may cause liver problems. Use under healthcare supervision and consult your doctor if you have concerns.
-
Market actionsRecall letters being dispatched
-
Market actions
-
-
-
Market actions
-
-
Market actionsFailure to comply with the mandatory absorbency requirements - AS/NZS 2869:1988 Tampons - menstrual.
-
Market actionsRecall due to failure to comply with the mandatory absorbency requirements of AS/NZS 2869:1988 Tampons - menstrual.
-
Safety alertsFact sheet to inform consumers about the safe use of paracetamol
-
Safety alertsThis fact sheet has been prepared by the Therapeutic Goods Administration to inform health practitioners about the safe use of paracetamol.
-
Market actionsRecall due to failure to comply with the requirements of TGO61 Contraceptive Rubber condoms.
-
-
Market actionsThe products have failed to comply with the relevant mandatory requirement for absorbency (AS/NZS 2869:1998 Tampons - Menstrual).
-
Market actionsIn 2003, the TGA recalled Pan Pharmaceuticals’ products due to serious safety and manufacturing issues.
-
Market actions
-
Market actions
-
-
Market actions
-
Market actions